Legal & General Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,120
| Closed | -$109K | – | 3649 |
|
|
2022
Q1 | $109K | Hold |
1,120
| – | – | ﹤0.01% | 2844 |
|
|
2021
Q4 | $183K | Buy |
1,120
+582
| +108% | +$128K | ﹤0.01% | 2757 |
|
|
2021
Q3 | $146K | Buy |
538
+283
| +111% | +$86.5K | ﹤0.01% | 2771 |
|
|
2021
Q2 | $102K | Sell |
255
-13
| -5% | -$6.07K | ﹤0.01% | 2726 |
|
|
2021
Q1 | $145K | Buy |
268
+43
| +19% | +$26.8K | ﹤0.01% | 2518 |
|
|
2020
Q4 | $85K | Sell |
225
-63
| -22% | -$25.1K | ﹤0.01% | 2631 |
|
|
2020
Q3 | $109K | Sell |
288
-64
| -18% | -$28.3K | ﹤0.01% | 2464 |
|
|
2020
Q2 | $173K | Buy |
352
+18
| +5% | +$8.03K | ﹤0.01% | 2386 |
|
|
2020
Q1 | $122K | Buy |
334
+44
| +15% | +$22.8K | ﹤0.01% | 2360 |
|
|
2019
Q4 | $205K | Buy |
290
+44
| +18% | +$30.3K | ﹤0.01% | 2394 |
|
|
2019
Q3 | $158K | Buy |
246
+41
| +20% | +$32.5K | ﹤0.01% | 2402 |
|
|
2019
Q2 | $179K | Buy |
205
+33
| +19% | +$22.7K | ﹤0.01% | 2375 |
|
|
2019
Q1 | $99K | Hold |
172
| – | – | ﹤0.01% | 2488 |
|
|
2018
Q4 | $48K | Buy |
172
+40
| +30% | +$15.8K | ﹤0.01% | 2713 |
|
|
2018
Q3 | $63K | Sell |
132
-88
| -40% | -$37.7K | ﹤0.01% | 2664 |
|
|
2018
Q2 | $100K | Sell |
220
-23
| -9% | -$14.6K | ﹤0.01% | 2501 |
|
|
2018
Q1 | $143K | Sell |
243
-70
| -22% | -$43.6K | ﹤0.01% | 2381 |
|
|
2017
Q4 | $193K | Hold |
313
| – | – | ﹤0.01% | 2327 |
|
|
2017
Q3 | $289K | Buy |
313
+15
| +5% | +$13.3K | ﹤0.01% | 2225 |
|
|
2017
Q2 | $279K | Buy |
298
+18
| +6% | +$17.6K | ﹤0.01% | 2193 |
|
|
2017
Q1 | $267K | Sell |
280
-3
| -1% | -$2.79K | ﹤0.01% | 2178 |
|
|
2016
Q4 | $227K | Buy |
283
+79
| +39% | +$71.2K | ﹤0.01% | 2198 |
|
|
2016
Q3 | $173K | Sell |
204
-10
| -5% | -$8.04K | ﹤0.01% | 2071 |
|
|
2016
Q2 | $177K | Hold |
214
| – | – | ﹤0.01% | 1824 |
|
|
2016
Q1 | $237K | Buy |
214
+65
| +44% | +$66.5K | ﹤0.01% | 1675 |
|
|
2015
Q4 | $184K | Hold |
149
| – | – | ﹤0.01% | 1779 |
|
|
2015
Q3 | $203K | Buy |
149
+39
| +35% | +$64.4K | ﹤0.01% | 1698 |
|
|
2015
Q2 | $197K | Buy |
110
+6
| +6% | +$9.31K | ﹤0.01% | 1756 |
|
|
2015
Q1 | $175K | Hold |
104
| – | – | ﹤0.01% | 1737 |
|
|
2014
Q4 | $81K | Hold |
104
| – | – | ﹤0.01% | 2126 |
|
|
2014
Q3 | $42K | Buy |
+104
| New | +$50.1K | ﹤0.01% | 2483 |
|
Other funds holding TCRT
MP
DCM
LCM
Legal & General Group's TCRT Position: Q2 2022 in Review
Legal & General Group sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 1,120 shares — an estimated $109K sold.
Legal & General Group first reported a position in TCRT in Q3 2014 and held it in 31 quarters. The position peaked at $289K in Q3 2017. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.
- Legal & General Group reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
- Legal & General Group sold 1,120 Alaunos Therapeutics shares in Q2 2022, an estimated $109K.
- Legal & General Group first reported a position in Alaunos Therapeutics in Q3 2014 and held it in 31 quarters.
- Legal & General Group's Alaunos Therapeutics position peaked at $289K in Q3 2017.
- 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.
Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.